In a study involving 65 dogs with mammary tumours (carcinosarcoma, tubulopapillary carcinoma and complex carcinoma), Ki‐67 expressions were negative in 49 dogs and weak in 16 dogs, suggesting Ki‐67 may not be an ideal candidate for diagnosing CMTs (Nielsen et al. This evidence concerns the gene MKI67 and breast cancer.